Astex Pharmaceuticals to Present at ROTH Conference

        Print
| Source: Astex Pharmaceuticals, Inc.

DUBLIN, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 25th Annual ROTH Conference on Tuesday March 19th in Laguna Niguel, California.

The Company's presentation will begin at 3:30 p.m. PT. A live webcast of the presentation will be available in the Investor Events section of the Company's website, www.astx.com. The webcast will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.

The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273

For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.

Timothy L. Enns
Astex Pharmaceuticals, Inc.
Senior Vice President
Corporate Communications & Marketing
Tel:  +1 (925) 560-2810
E-mail:  

Susanna Chau
Astex Pharmaceuticals, Inc.
Manager
Investor Relations
Tel:  +1 (925) 560-2845
E-mail:  

Alan Roemer
The Trout Group
Managing Director
Tel:  +1 (646) 378-2945
E-mail: